Adenosine single photon emission computed tomography for assessing risk after myocardial infarction: recent...

Area of Science:

• Cardiology
• Nuclear Cardiology
• Cardiovascular Imaging

Background:

• Adenosine single photon emission computed tomography myocardial perfusion imaging (SPECT MPI) is validated for risk stratification in coronary artery disease.
• Its role in the primary angioplasty era post-acute myocardial infarction (AMI) remains debated.

Purpose of the Study:

• To evaluate the prognostic utility of early SPECT MPI in patients after AMI treated with primary angioplasty.
• To assess the effectiveness of intensive medical therapy versus revascularization in this population.

Main Methods:

• The INSPIRE trial investigated early SPECT MPI for risk stratification in stable post-AMI patients.
• Patients received intensive medical therapy, with outcomes compared across risk strata.

Main Results:

• Early SPECT MPI successfully identified low-risk patients eligible for early hospital discharge post-AMI.
• Intensive medical therapy proved effective in managing low, intermediate, and high-risk patients with preserved left ventricular function.

Conclusions:

• The INSPIRE trial supports early SPECT MPI for risk stratification in stable post-AMI patients.
• Intensive medical therapy demonstrated comparable efficacy to revascularization in managing ischemia and improving cardiac outcomes.